✦ LIBER ✦

Timing of Conversion to Mammalian Target of Rapamycin Inhibitors Is Crucial in Liver Transplant Recipients With Impaired Renal Function at Transplantation

✍ Scribed by C. Schleicher; D. Palmes; M. Utech; E. Bonrath; N. Senninger; H. Schmidt; H. Wolters

Book ID: 116936424
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 180 KB
Volume: 42
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2010.05.159

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pneumonitis Associated With Mammalian Ta

Pneumonitis Associated With Mammalian Target of Rapamycin Inhibitors in Renal Transplant Recipients: A Single-Center Experience

✍ P. Errasti; D. Izquierdo; P. Martín; M. Errasti; F. Slon; A. Romero; F.J. Lavill 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Low-Dose Calcineurin Inhibitor Regimen C

Low-Dose Calcineurin Inhibitor Regimen Combined With Mammalian Target of Rapamycin Inhibitors Preserves Kidney Functions in Renal Transplant Recipients Without Allograft Nephropathy

✍ S. Kacar; A. Gurkan; C. Karaca; C. Varılsuha; S. Tilif 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Antitumor Efficacy of Mammalian Target o

Antitumor Efficacy of Mammalian Target of Rapamycin Inhibitor Therapy in Liver Transplant Recipients With Oncological Disease: A Case-Control Study

✍ Álamo, J.M.; Bernal, C.; Marín, L.M.; Suárez, G.; Serrano, J.; Barrera, L.; Sous 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 125 KB

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin

Improvement of Renal Function After Conv

Improvement of Renal Function After Conversion to Mycophenolate Mofetil Combined With Low-Level Calcineurin Inhibitor in Liver Transplant Recipients With Chronic Renal Dysfunction

✍ C. Ponton; L. Vizcaíno; S. Tomé; E. Otero; E. Molina; J.F. Castroagudín; A. Lópe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Conversion to mycophenolate mofetil (MMF

Conversion to mycophenolate mofetil (MMF) instead of cyclosporine a (CYA) in liver transplant (LT) recipients with renal function impairment. A pilot study

✍ J.I. Herrero; J. Quiroga; B. Sangro; M. Girala; N. Gómez; A. Beltrán; F. Pardo; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 159 KB